Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia
Document Type
Article
Publication Date
3-1-2026
Abstract
Background: Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches. Objectives: To assess the need for anticholinergic medications and botulinum neurotoxin injections in adult and pediatric patients at two specialized Canadian centers before and after DBS over the past 10 years. Methods: 58 patients were included analyzing data before, 6 and 12 months after DBS. Clinical assessment included the Toronto Western Spasmodic Torticollis Rating Scale and Fahn-Marsden Dystonia Rating Scale. Anticholinergic burden was determined by the Anticholinergic Drug Scale (ADS). Results: Severity of cervical dystonia and ADS scores reduction were statistically significant after DBS. Anticholinergic medication and Botulinum Neurotoxin injections were discontinued a year after surgery in 28.8% and 72.4% of the patients, respectively. Conclusion: Simplification of anti-dystonia treatments is another added benefit of DBS.
Keywords
anticholinergic, botulinum neurotoxin, deep brain stimulation, dystonia, treatment
Publication Title
Movement Disorders Clinical Practice
ISSN
2330-1619
DOI
10.1002/mdc3.70370
Recommended Citation
Montiel, Marcela A.; Magliozzi, Alessandro; Lim, Wei Kang; Gorodetsky, Carolina; Ibrahim, George M.; Fasano, Alfonso; and Universiti Malaya, "Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia" (2026). Research Publications (2026 to 2030). 1205.
https://knova.um.edu.my/research_publications_2026_2030/1205
Volume
13
Issue
3
First Page
774
Last Page
778
Publisher
John Wiley and Sons Inc